Connect with us

Hi, what are you looking for?


FDA warns against unapproved vaccines

THE FOOD and Drug Administration (FDA) on Monday cautioned against the use of unapproved coronavirus vaccines after reports that some people have been inoculated.

“The FDA has not issued any emergency use authorization to any vaccine for COVID-19 (coronavirus disease 2019),” FDA Director General Rolando Enrique D. Domingo said in a statement on Monday.

“Without proper authorization, there is no guarantee on the safety, quality and efficacy of said vaccine as the same has not undergone the required technical evaluation by the FDA,” he added.

The Department of Health (DoH) reported 766 coronavirus infections on Monday, bringing the total to 470,650.

The death toll rose by 15 to 9,124, while recoveries increased by 104 to 438,780, it said in a bulletin.

There were 22,746 active cases, 80% of which were mild, 10.4% did not show symptoms, 3.2% were severe and 6% were critical.

Davao City reported the highest number of new cases at 60, followed by Quezon City at 46, Benguet at 41, Laguna at 39 and Rizal at 37.

The agency said two duplicates had been removed from the tally, while one tagged as recovered was reclassified as a death.

DoH said it expects cases to fall between Dec. 24 and Jan. 4 as fewer people get tested during the holiday.

It said eight laboratories were closed on Dec. 26. Out of the 175 laboratories that were open, 27 reported zero testing.

The Philippine government expects millions of coronavirus vaccine doses to arrive next year as it continues negotiations with drug companies for supply. 

The state is in talks with British drugmaker AstraZeneca Plc for 20 million doses that will be allotted to the government, and 10 million more for the private sector, vaccine czar Carlito G. Galvez, Jr. said at the weekend.

The government was also signing a contract with Serum Institute of India Ptv. Ltd. by January, which had committed 30 million doses for the Philippines.

The state was also in talks with US drug company Pfizer, Inc., while Moderna, Inc. has agreed to ship 20 million doses. Pfizer and Moderna are frontrunners in vaccine development, both reporting more than 90% efficacy rate. — Charmaine A. Tadalan

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



WASHINGTON D.C. — The United States is seeking to form a coalition of countries to drive negotiations on a global plastic pollution treaty, weeks...


By Diego Gabriel C. Robles  THE WORLD BANK (WB) upgraded its growth forecast for the Philippines for this year and 2023, citing an “accommodative”...


THE PHILIPPINE auto industry’s sales recovery will likely be derailed if a measure reimposing excise taxes on pickup trucks is signed into law, according...


THE BANGKO SENTRAL ng Pilipinas (BSP) may deliver a second off-cycle rate hike in early November when the US Federal Reserve is expected to...


THE ASIAN Development Bank (ADB) is planning to allocate at least $14 billion for a program aimed at easing a food crisis in the...


With the reversal of the 1.25% rise in National Insurance Contributions happening on the 6th of November, employers across the nation have an opportunity...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.